Publication:
Childhood Systemic Lupus Erythematosus: A Tertiary Care Centre Experience

creativeworkseries.issnISSN 1990-7974 eISSN 1990-7982
dc.contributor.authorBajracharya, Luna
dc.contributor.authorThapa, Surya Bahadur
dc.date.accessioned2026-03-19T09:03:59Z
dc.date.available2026-03-19T09:03:59Z
dc.date.issued2015
dc.descriptionLuna Bajracharya Department of Paediatrics, Tribhuvan University Teaching Hospital, Kathmandu Surya Bahadur Thapa Department of Paediatrics, Tribhuvan University Teaching Hospital, Kathmandu
dc.description.abstractAbstract: Introduction: Systemic lupus erythematosus (SLE) is a chronic immunologic disorder with multisystem manifestations. Even more awareness is required to diagnose the disease at younger age. Objective of this study was to explore clinico-laboratory manifestations and management of SLE in children at Tribhuvan University Teaching Hospital (TUTH). Materials and Methods: The study was retrospective hospital based study conducted from 15th July, 2008 to 14th July, 2014. Medical charts of all children and adolescent (6- 16years of age) with SLE admitted at TUTH were reviewed for analysis of data. Results: The total number of patients was 33, with 28(84.8%) girls and 5 (15.2%) boys. The mean age of diagnosis was 12.12 (SD 1.89). Facial puffiness (27.3%) and arthralgia (24.2%) were the commonest presentations at disease onset. The most frequent clinical features during the entire course of illness were edema (78.9%), anemia (69.7%) and fever (66.7%). Twenty three (69.6%) patients underwent renal biopsy in which class IV was the commonest lupus nephritis. The commonly used drugs after prednisolone were intravenous cyclophosphamide, intravenouse methylprednisolone and mycophenolate mofetil. Total 17 (51.5%) patients went into remission. Two patients died due to active lupus and four due to sepsis. Conclusion: Lupus nephritis was the commonest feature at disease onset, at the time of diagnosis and throughout the disease course among Nepalese children with SLE. The most frequently used medications were prednisolone and iv cyclophosphamide. Infection and active lupus were the leading causes of complications and death.
dc.identifierhttps://doi.org/10.3126/jnps.v35i2.13282
dc.identifier.urihttps://hdl.handle.net/20.500.14572/5234
dc.language.isoen_US
dc.publisherNepal Paediatric Society (JNPS)
dc.subjectANA
dc.subjectChildhood systemic lupus erythematosus
dc.subjectLupus nephritis
dc.titleChildhood Systemic Lupus Erythematosus: A Tertiary Care Centre Experience
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage116
oaire.citation.startPage111
relation.isJournalIssueOfPublicationbfb56e84-1501-4226-8a7b-aea91047797e
relation.isJournalIssueOfPublication.latestForDiscoverybfb56e84-1501-4226-8a7b-aea91047797e
relation.isJournalOfPublication6f9be05c-05a9-4a3e-a5b5-a19a15ab042c

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
111-116.pdf
Size:
268.5 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections